Intuitive Surgical Stock - Bank of America trims price target on margin concerns

Bank of America Securities has slightly lowered its price target for Intuitive Surgical while keeping a Buy rating. On this Wednesday the focus for investors stays on the company’s operational strategy and growth levers around robotic-assisted surgery.

Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 18:13 CET. Details in the imprint.

Intuitive Surgical (US46120E6023) remains a key name in robotic-assisted surgery today. Bank of America Securities has marginally reduced its price target while reiterating a Buy rating, according to a recent analyst update.

Bank of America adjusts target

According to a recent note summarized by financial media, Bank of America Securities analyst Travis Steed cut his price target for Intuitive Surgical from $520 to $515 while keeping a Buy rating on the stock, citing inflation-driven margin headwinds.

The analyst points to higher cost pressures that could temper margin expansion, but he still expects solid demand for robotic procedures and system placements over the medium term. The move is a minor adjustment rather than a fundamental rating shift.

Operations and strategy on Wednesday

Beyond single analyst moves, investors are watching how Intuitive Surgical executes on its strategy to grow installed da Vinci systems and expand procedure types. The company highlighted procedure growth and utilization as key levers in its recent quarterly update.

Management has also emphasized ongoing R&D and next-generation platforms as central to its long-term plan, aiming to deepen penetration in general surgery and other specialties while supporting hospitals with training and service offerings.

How the company makes money

Intuitive Surgical generates revenue primarily from sales of its da Vinci surgical systems, recurring instrument and accessory revenue tied to each procedure, and service contracts on installed systems. This mix creates a growing base of recurring income as procedures increase.

Where the stock trades today

Intuitive Surgical stock (US46120E6023) trades on Nasdaq; the latest verified price data point is not available with a precise timestamp, so only the listing venue can be stated here without a current quote.

Key facts on Intuitive Surgical stock

• Company: Intuitive Surgical, Inc.
• ISIN: US46120E6023
• WKN: 888024
• Ticker: ISRG
• Venue: Nasdaq
• Sector / Industry: Health Care - Medical Devices
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.